UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the
month of November 2024
Commission
File Number 001-15170
GSK plc
(Translation
of registrant's name into English)
79 New Oxford Street, London, WC1A 1DG
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form
20-F . . . .X. . . . Form 40-F . . . . . . . .
GSK plc
GSK publishes provisional dividend dates
GSK announces the following dividend dates for
2025:
These dates are indicative and may be subject to
change.
|
Results
|
Announcement date
|
Ordinary Shares
Ex-dividend date
|
American Depositary Shares
Ex-dividend date
|
Record date
|
Last date for DRIP elections
|
Payable
|
|
Q1 2025
|
Wednesday 30 April 2025
|
Thursday 15 May 2025
|
Friday 16 May 2025
|
Friday 16 May 2025
|
Thursday 19 June 2025
|
Thursday 10 July 2025
|
|
Q2 2025
|
Wednesday 30 July 2025
|
Thursday 14 August 2025
|
Friday 15 August 2025
|
Friday 15 August 2025
|
Thursday 18 September 2025
|
Thursday 9 October 2025
|
|
Q3 2025
|
Wednesday 29 October 2025
|
Thursday 13 November 2025
|
Friday 14 November 2025
|
Friday 14 November 2025
|
Monday 15 December 2025
|
Thursday 8 January 2026
|
|
Q4 2025
|
Wednesday 4 February 2026
|
Thursday 19 February 2026
|
Friday 20 February 2026
|
Friday 20 February 2026
|
Tuesday 17 March 2026
|
Thursday 9 April 2026
|
V A Whyte
Company Secretary
11 November 2024
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorised.
|
|
GSK plc
|
|
|
(Registrant)
|
|
|
|
|
Date: November
11, 2024
|
|
|
|
|
|
|
By:/s/ VICTORIA
WHYTE
--------------------------
|
|
|
|
|
|
Victoria Whyte
|
|
|
Authorised
Signatory for and on
|
|
|
behalf
of GSK plc
|